Nifty Midcap Select News and Updates

Name: Latest research reports of Aurobindo Pharma Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aurobindo Pharma Ltd.
Rating: 5
Author: Axis Direct

Keep track of all breaking news on Nifty Midcap Select from all sources in a single place.

Load latest

Aurobindo Pharma Ltd.

28 May 2025

1082.50

-2.06%

Result Update:Aurobindo Pharma

Buy: Aurobindo Pharma Ltd.

Axis Direct

We maintain our BUY recommendation on Aurobindo Pharma with a TP of Rs 1,500/share.

Aurobindo Pharma Ltd. is trading below all available SMAs

Vodafone Idea Ltd.

27 May 2025

6.33

-3.51%

Vodafone Idea board to review fundraising plans, Q4 results on May 30

Business Standard

The board of debt-ridden firm Vodafone Idea will meet on May 30 to consider fundraising options along with approval of its financial results, the company said on Tuesday. The loss-making firm has expressed apprehension about its survival beyond the current fiscal due to liquidity crunch in the company despite financial support from the government. In a BSE filing, Vodafone Idea said that its board will meet on May 30 "to consider and evaluate any and all proposals for raising of funds in one or more tranches, either by way of a rights issue or further public offer or private placement (including preferential allotment or qualified institutions placement)." The board will also evaluate fundraising through any other permissible mode including debt bonds. The board will decide on holding extraordinary general meeting to get shareholders' nod for the fundraise on the same day. Vodafone Idea board will also meet and consider approving its financial performance for the March 2025 quarte

Vodafone Idea Ltd. is trading below all available SMAs

Vodafone Idea Board To Consider Fundraise On May 30 As AGR Trouble Mounts

NDTV Profit | 27 May 2025

Ashok Leyland Ltd.

27 May 2025

232.86

-0.48%

Demand and margin gains to power M&CV company Ashok Leyland's stock

Business Standard

Ashok Leyland's strong Q4 led by 5% volume growth and margin gains; focus on exports, non-CV business and cost control to support performance in FY26

Ashok Leyland Ltd. is trading above its 200 day SMA of 223.3

Dixon Technologies (India) Ltd.

27 May 2025

14004.00

-2.53%

Dixon Technologies eyes revenue of around 1,500 crore this fiscal year from the new plant in Chennai

Business Line

Pilot run for manufacturing laptops has been completed, and mass production has already commenced

Dixon Technologies (India) Ltd. has lost -15.94% in the last 1 Month

Aurobindo Pharma Ltd.

27 May 2025

1082.50

-2.06%

Aurobindo Pharma Share Price Rises After Q4 Revenue Growth

NDTV Profit

Aurobindo Pharma reported a consolidated revenue increase of 10.6% year-on-year, reaching Rs 8,382 crore in Q4 FY25.

Aurobindo Pharma Ltd. is trading below all available SMAs

Aurobindo Pharma Q4 results: Profit dips to 903 cr, revenue up 11%

Business Standard | 26 May 2025 5 more

Colgate-Palmolive (India) Ltd.

27 May 2025

2399.70

0.05%

Colgate Palmolive Dividend: Last Day To Buy Shares To Qualify Details Here

NDTV Profit

Colgate Palmolive's board announced a second interim dividend of Rs 27 per share for financial year 2025.

Number of FII/FPI investors decreased from 943 to 892 in Mar 2025 qtr

Ashok Leyland Ltd.

27 May 2025

232.86

-0.48%

Ashok Leyland Aims To Make EV Arm Switch Mobility Fund Own Capex

NDTV Profit

CEO Shenu Agarwal describes the decision to issue a bonus as a gesture to 'reward our shareholders further'.

Promoters pledged 11.05% of shares in last quarter. Total pledge stands at 41.15% of promoter holdings

Broker's call: Ashok Leyland (Outperform)

Business Line | 26 May 2025 5 more

Colgate-Palmolive (India) Ltd.

27 May 2025

2399.70

0.05%

Soft Q4; recovery to be gradual

Buy: Colgate-Palmolive (India) ...

Recommendation Target

Sharekhan

Colgate’s Q4FY25 performance was muted owing to soft demand in urban markets and heightened competitive intensity. Standalone revenues declined by 1.8% y-o-y to Rs. 1,463 crore, missing our expectation of Rs. 1,520 crore, with toothpaste volumes flat y-o-y.

Colgate-Palmolive (I.. has an average target of 2729.25 from 8 brokers.

Aurobindo Pharma Ltd.

27 May 2025

1082.50

-2.06%

Aurobindo Pharma (ARBP IN) Q4FY25 Result Update Resumption...

Buy: Aurobindo Pharma Ltd.

Target

Prabhudas Lilladhar

Aurobindo Pharma's (ARBP) Q4FY25 EBITDA of Rs17.9bn (up 6% YoY) was in line with our estimate. FY26 guidance of high single digit revenue growth ex gRevlimid with flat margins was below our estimate. Resultant our FY26 and FY27E EPS stands reduced by 4-5%. Other expenses remained elevated on the back of higher PenG-related operational cost and supply disruptions due to...

Aurobindo Pharma Ltd. has an average target of 1493.80 from 10 brokers.

Bharat Heavy Electricals Ltd.

26 May 2025

247.20

-1.83%

No cause of worry, infection severity mild: ICMR DG amid Covid cases uptick

Business Standard

Amid an uptick in Covid cases in some parts of the country, Director General of the Indian Council of Medical Research (ICMR) Dr Rajiv Behl Monday said the severity of infections as of now is generally mild and there was no cause for worry. Speaking about new Covid variants being traced, he said genome sequencing of samples in the west and south have shown that the new variants are not severe and are Omicron sub-variants. These are LF.7, XFG, JN.1 and NB. 1.8.1. The first three are more prevalent, Dr Bhel said. "Samples from other places are being sequenced and we will know in a day or two if there are more variants." The ICMR DG said there has been an uptick in cases --first from the south, then west and now from northern India. All these cases are being monitored through the Integrated Disease Surveillance Programme (IDSP). Besides that, ICMR's nationwide respiratory virus sentinel surveillance network is keeping a watch on emerging infections and pathogens, he said. "Whenever c

Bharat Heavy Electricals Ltd. has gained 21.25% in the last 3 Months

Nifty Midcap Select PB	8.4
Nifty Midcap Select PE	52.1
Nifty Midcap Select DIV	0.7
Nifty Midcap Select EPS	244.2

Nifty Midcap Select PB

Nifty Midcap Select PE

Nifty Midcap Select DIV

Nifty Midcap Select EPS

Nifty Midcap Select News and Updates

Keep track of all breaking news on Nifty Midcap Select from all sources in a single place.